Antipsychotic Monitoring Within the Home Treatment Team in the Southern Trust, a Quality Improvement Project
AimsThe Royal College of Psychiatrists has a specialist group called the Home Treatment Accreditation Scheme (HTAS) that has published a set of best practice recommendations for Home Treatment Crisis Response (HTCR) teams across the UK. As of yet, the HTCR team in the Southern Trust is not accredite...
Gespeichert in:
Veröffentlicht in: | BJPsych open 2022-06, Vol.8 (S1), p.S83-S83 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S83 |
---|---|
container_issue | S1 |
container_start_page | S83 |
container_title | BJPsych open |
container_volume | 8 |
creator | Andress, Cedar Coulter, Paul Watson, Leah |
description | AimsThe Royal College of Psychiatrists has a specialist group called the Home Treatment Accreditation Scheme (HTAS) that has published a set of best practice recommendations for Home Treatment Crisis Response (HTCR) teams across the UK. As of yet, the HTCR team in the Southern Trust is not accredited. We decided to focus our project on antipsychotic monitoring. SMART aim: All patients (100%) within the HTCR team commenced on antipsychotics are receiving an appropriate level of blood and physical monitoring as recommended by guidelines and these are being documented correctly within 10 days of discharge.MethodsPLANHTAS standards were reviewed alongside NICE guidelines on antipsychotic monitoring and a pro forma created. We collected baseline data on patients commenced on treatment dose antipsychotics in the HTCR team and assessed completion of bloods/ECGs/physical parameters and documentation.DOOur intervention for PSDA cycle 1 was to educate members of the multi- disciplinary team (MDT) via a presentation after the baseline data were analysed. We looked at correct documentation and how to fix common mistakes identified. We asked staff for their input on how to improve outcomes. Posters were printed off for guidance. We collected data after this intervention using the same pro forma.STUDYWe analysed the results from PSDA cycle 1, comparing them to baseline results.ACTOur next step in PDSA cycle 2 would be to focus on continuing to improve poorer results such as prolactin levels and ECGs, with input from the MDT.ResultsBaseline data showed between a 14% and 59% completion rate for various baseline bloods, 68–72% completion rate for heart rate (HR)/blood pressure (BP)/weight and a 36% completion rate for ECGs.Following PDSA cycle 1, this improved to between a 55–100% completion rate for baseline bloods, a 91% completion rate for HR/BP/weight and a 64% completion rate for ECGs.Baseline documentation of these parameters was correctly recorded between 9–68% of the time. This overall improved after PSDA cycle 1 to 18–73%.ConclusionOur intervention from PDSA cycle 1 improved completion of bloods, physical parameters and ECGs in the HTCR team. Documentation also improved in all domains.Our next step in PDSA cycle 2 would be to focus on continuing to improve poorer results, looking at altering practicalities that may have affected those areas. |
doi_str_mv | 10.1192/bjo.2022.270 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9378063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1192_bjo_2022_270</cupid><sourcerecordid>2678242344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1970-ba34dab2bd4eeae284b4668fd4a56e285bf6db74cc503f5e01cb1aca04fa9cfc3</originalsourceid><addsrcrecordid>eNptUVtLwzAULqLgmL75AwK-rjVJ09uLMIa6wUTFiY8hSdM1pW1qmg72781c8QI-nXP4LueDz_OuEAwQyvANr3SAIcYBTuCJN8Ewin2SYHL6az_3Lvu-ghCiKCFJSiZePW-t6vq9KLVVAjzqVlltVLsF78qWqgW2lGCpGwk2RjLbyNaCjWQNGKFXPbhhWgcPvZ0BBl4GViu7B6umM3onvxTPRldS2AvvrGB1Ly_HOfXe7u82i6W_fnpYLeZrX6AsgT5nIckZxzwnUjKJU8JJHKdFTlgUuzPiRZzzhAgRwbCIJESCIyYYJAXLRCHCqXd79O0G3shcuAiG1bQzqmFmTzVT9C_SqpJu9Y5mYZLCOHQG16OB0R-D7C2t9GBal5niOEkxwSEhjjU7soTRfW9k8f0BQXrohLpO6KET6jpx9GCks4YblW_lj-u_gk_PbZIU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678242344</pqid></control><display><type>article</type><title>Antipsychotic Monitoring Within the Home Treatment Team in the Southern Trust, a Quality Improvement Project</title><source>Cambridge Journals Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Andress, Cedar ; Coulter, Paul ; Watson, Leah</creator><creatorcontrib>Andress, Cedar ; Coulter, Paul ; Watson, Leah</creatorcontrib><description>AimsThe Royal College of Psychiatrists has a specialist group called the Home Treatment Accreditation Scheme (HTAS) that has published a set of best practice recommendations for Home Treatment Crisis Response (HTCR) teams across the UK. As of yet, the HTCR team in the Southern Trust is not accredited. We decided to focus our project on antipsychotic monitoring. SMART aim: All patients (100%) within the HTCR team commenced on antipsychotics are receiving an appropriate level of blood and physical monitoring as recommended by guidelines and these are being documented correctly within 10 days of discharge.MethodsPLANHTAS standards were reviewed alongside NICE guidelines on antipsychotic monitoring and a pro forma created. We collected baseline data on patients commenced on treatment dose antipsychotics in the HTCR team and assessed completion of bloods/ECGs/physical parameters and documentation.DOOur intervention for PSDA cycle 1 was to educate members of the multi- disciplinary team (MDT) via a presentation after the baseline data were analysed. We looked at correct documentation and how to fix common mistakes identified. We asked staff for their input on how to improve outcomes. Posters were printed off for guidance. We collected data after this intervention using the same pro forma.STUDYWe analysed the results from PSDA cycle 1, comparing them to baseline results.ACTOur next step in PDSA cycle 2 would be to focus on continuing to improve poorer results such as prolactin levels and ECGs, with input from the MDT.ResultsBaseline data showed between a 14% and 59% completion rate for various baseline bloods, 68–72% completion rate for heart rate (HR)/blood pressure (BP)/weight and a 36% completion rate for ECGs.Following PDSA cycle 1, this improved to between a 55–100% completion rate for baseline bloods, a 91% completion rate for HR/BP/weight and a 64% completion rate for ECGs.Baseline documentation of these parameters was correctly recorded between 9–68% of the time. This overall improved after PSDA cycle 1 to 18–73%.ConclusionOur intervention from PDSA cycle 1 improved completion of bloods, physical parameters and ECGs in the HTCR team. Documentation also improved in all domains.Our next step in PDSA cycle 2 would be to focus on continuing to improve poorer results, looking at altering practicalities that may have affected those areas.</description><identifier>ISSN: 2056-4724</identifier><identifier>EISSN: 2056-4724</identifier><identifier>DOI: 10.1192/bjo.2022.270</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Antipsychotics ; Documentation ; Poster Presentations ; Psychotropic drugs ; Quality Improvement</subject><ispartof>BJPsych open, 2022-06, Vol.8 (S1), p.S83-S83</ispartof><rights>Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists</rights><rights>Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022 2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378063/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S2056472422002708/type/journal_article$$EHTML$$P50$$Gcambridge$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,23297,27901,27902,53766,53768,55779</link.rule.ids></links><search><creatorcontrib>Andress, Cedar</creatorcontrib><creatorcontrib>Coulter, Paul</creatorcontrib><creatorcontrib>Watson, Leah</creatorcontrib><title>Antipsychotic Monitoring Within the Home Treatment Team in the Southern Trust, a Quality Improvement Project</title><title>BJPsych open</title><addtitle>BJPsych open</addtitle><description>AimsThe Royal College of Psychiatrists has a specialist group called the Home Treatment Accreditation Scheme (HTAS) that has published a set of best practice recommendations for Home Treatment Crisis Response (HTCR) teams across the UK. As of yet, the HTCR team in the Southern Trust is not accredited. We decided to focus our project on antipsychotic monitoring. SMART aim: All patients (100%) within the HTCR team commenced on antipsychotics are receiving an appropriate level of blood and physical monitoring as recommended by guidelines and these are being documented correctly within 10 days of discharge.MethodsPLANHTAS standards were reviewed alongside NICE guidelines on antipsychotic monitoring and a pro forma created. We collected baseline data on patients commenced on treatment dose antipsychotics in the HTCR team and assessed completion of bloods/ECGs/physical parameters and documentation.DOOur intervention for PSDA cycle 1 was to educate members of the multi- disciplinary team (MDT) via a presentation after the baseline data were analysed. We looked at correct documentation and how to fix common mistakes identified. We asked staff for their input on how to improve outcomes. Posters were printed off for guidance. We collected data after this intervention using the same pro forma.STUDYWe analysed the results from PSDA cycle 1, comparing them to baseline results.ACTOur next step in PDSA cycle 2 would be to focus on continuing to improve poorer results such as prolactin levels and ECGs, with input from the MDT.ResultsBaseline data showed between a 14% and 59% completion rate for various baseline bloods, 68–72% completion rate for heart rate (HR)/blood pressure (BP)/weight and a 36% completion rate for ECGs.Following PDSA cycle 1, this improved to between a 55–100% completion rate for baseline bloods, a 91% completion rate for HR/BP/weight and a 64% completion rate for ECGs.Baseline documentation of these parameters was correctly recorded between 9–68% of the time. This overall improved after PSDA cycle 1 to 18–73%.ConclusionOur intervention from PDSA cycle 1 improved completion of bloods, physical parameters and ECGs in the HTCR team. Documentation also improved in all domains.Our next step in PDSA cycle 2 would be to focus on continuing to improve poorer results, looking at altering practicalities that may have affected those areas.</description><subject>Antipsychotics</subject><subject>Documentation</subject><subject>Poster Presentations</subject><subject>Psychotropic drugs</subject><subject>Quality Improvement</subject><issn>2056-4724</issn><issn>2056-4724</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>IKXGN</sourceid><sourceid>BENPR</sourceid><recordid>eNptUVtLwzAULqLgmL75AwK-rjVJ09uLMIa6wUTFiY8hSdM1pW1qmg72781c8QI-nXP4LueDz_OuEAwQyvANr3SAIcYBTuCJN8Ewin2SYHL6az_3Lvu-ghCiKCFJSiZePW-t6vq9KLVVAjzqVlltVLsF78qWqgW2lGCpGwk2RjLbyNaCjWQNGKFXPbhhWgcPvZ0BBl4GViu7B6umM3onvxTPRldS2AvvrGB1Ly_HOfXe7u82i6W_fnpYLeZrX6AsgT5nIckZxzwnUjKJU8JJHKdFTlgUuzPiRZzzhAgRwbCIJESCIyYYJAXLRCHCqXd79O0G3shcuAiG1bQzqmFmTzVT9C_SqpJu9Y5mYZLCOHQG16OB0R-D7C2t9GBal5niOEkxwSEhjjU7soTRfW9k8f0BQXrohLpO6KET6jpx9GCks4YblW_lj-u_gk_PbZIU</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Andress, Cedar</creator><creator>Coulter, Paul</creator><creator>Watson, Leah</creator><general>Cambridge University Press</general><scope>IKXGN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20220601</creationdate><title>Antipsychotic Monitoring Within the Home Treatment Team in the Southern Trust, a Quality Improvement Project</title><author>Andress, Cedar ; Coulter, Paul ; Watson, Leah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1970-ba34dab2bd4eeae284b4668fd4a56e285bf6db74cc503f5e01cb1aca04fa9cfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antipsychotics</topic><topic>Documentation</topic><topic>Poster Presentations</topic><topic>Psychotropic drugs</topic><topic>Quality Improvement</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andress, Cedar</creatorcontrib><creatorcontrib>Coulter, Paul</creatorcontrib><creatorcontrib>Watson, Leah</creatorcontrib><collection>Cambridge Journals Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Psychology</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BJPsych open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andress, Cedar</au><au>Coulter, Paul</au><au>Watson, Leah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antipsychotic Monitoring Within the Home Treatment Team in the Southern Trust, a Quality Improvement Project</atitle><jtitle>BJPsych open</jtitle><addtitle>BJPsych open</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>8</volume><issue>S1</issue><spage>S83</spage><epage>S83</epage><pages>S83-S83</pages><issn>2056-4724</issn><eissn>2056-4724</eissn><abstract>AimsThe Royal College of Psychiatrists has a specialist group called the Home Treatment Accreditation Scheme (HTAS) that has published a set of best practice recommendations for Home Treatment Crisis Response (HTCR) teams across the UK. As of yet, the HTCR team in the Southern Trust is not accredited. We decided to focus our project on antipsychotic monitoring. SMART aim: All patients (100%) within the HTCR team commenced on antipsychotics are receiving an appropriate level of blood and physical monitoring as recommended by guidelines and these are being documented correctly within 10 days of discharge.MethodsPLANHTAS standards were reviewed alongside NICE guidelines on antipsychotic monitoring and a pro forma created. We collected baseline data on patients commenced on treatment dose antipsychotics in the HTCR team and assessed completion of bloods/ECGs/physical parameters and documentation.DOOur intervention for PSDA cycle 1 was to educate members of the multi- disciplinary team (MDT) via a presentation after the baseline data were analysed. We looked at correct documentation and how to fix common mistakes identified. We asked staff for their input on how to improve outcomes. Posters were printed off for guidance. We collected data after this intervention using the same pro forma.STUDYWe analysed the results from PSDA cycle 1, comparing them to baseline results.ACTOur next step in PDSA cycle 2 would be to focus on continuing to improve poorer results such as prolactin levels and ECGs, with input from the MDT.ResultsBaseline data showed between a 14% and 59% completion rate for various baseline bloods, 68–72% completion rate for heart rate (HR)/blood pressure (BP)/weight and a 36% completion rate for ECGs.Following PDSA cycle 1, this improved to between a 55–100% completion rate for baseline bloods, a 91% completion rate for HR/BP/weight and a 64% completion rate for ECGs.Baseline documentation of these parameters was correctly recorded between 9–68% of the time. This overall improved after PSDA cycle 1 to 18–73%.ConclusionOur intervention from PDSA cycle 1 improved completion of bloods, physical parameters and ECGs in the HTCR team. Documentation also improved in all domains.Our next step in PDSA cycle 2 would be to focus on continuing to improve poorer results, looking at altering practicalities that may have affected those areas.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><doi>10.1192/bjo.2022.270</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2056-4724 |
ispartof | BJPsych open, 2022-06, Vol.8 (S1), p.S83-S83 |
issn | 2056-4724 2056-4724 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9378063 |
source | Cambridge Journals Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Antipsychotics Documentation Poster Presentations Psychotropic drugs Quality Improvement |
title | Antipsychotic Monitoring Within the Home Treatment Team in the Southern Trust, a Quality Improvement Project |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T04%3A49%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antipsychotic%20Monitoring%20Within%20the%20Home%20Treatment%20Team%20in%20the%20Southern%20Trust,%20a%20Quality%20Improvement%20Project&rft.jtitle=BJPsych%20open&rft.au=Andress,%20Cedar&rft.date=2022-06-01&rft.volume=8&rft.issue=S1&rft.spage=S83&rft.epage=S83&rft.pages=S83-S83&rft.issn=2056-4724&rft.eissn=2056-4724&rft_id=info:doi/10.1192/bjo.2022.270&rft_dat=%3Cproquest_pubme%3E2678242344%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2678242344&rft_id=info:pmid/&rft_cupid=10_1192_bjo_2022_270&rfr_iscdi=true |